Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lynk Pharmaceuticals Co., Ltd

Clinical trials sponsored by Lynk Pharmaceuticals Co., Ltd, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for stubborn arthritis: Final-Stage drug trial underway

Disease control Ongoing

This study is testing an experimental pill called LNK01001 for people with moderate-to-severe rheumatoid arthritis whose symptoms aren't controlled by other powerful injectable medications. About 430 participants will take either the new drug or a placebo pill for 24 weeks, follo…

Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC